The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry
Abstract
Rationale: The Cystic Fibrosis Foundation Patient Registry (CFFPR) is an ongoing patient registry study that collects longitudinal demographic, clinical, and treatment information about persons with cystic fibrosis (CF) in the United States. CF is a life-shortening genetic disorder that occurs in approximately 1 in 3,500 births in the United States. High-quality observational data is important for clinical research, quality improvement, and clinical management. Objectives: To describe the data collection, patient population, and key limitations of the CFFPR. Methods: Inclusion criteria for the CFFPR include diagnosis with CF or a CFTR-associated disorder, care at an accredited care center program, and provision of informed consent. Data from clinic visits and hospitalizations are collected through a secure website. Loss to follow-up and generalizability were examined using several methods. The accuracy of CFFPR data was evaluated with an audit of 2012 CFFPR data compared to the medical record. Measurements and Main Results: Since 1986, the CFFPR contains the records of 48,463 individuals with CF. Participation among individuals seen at accredited care centers is high, and loss to follow-up is low. An audit of 2012 CFFPR data suggests that the CFFPR contains 95% of clinic visits and 90% of hospitalizations found in the medical record for these patients, and nearly all of the audited fields were highly accurate. Conclusions: Registries such as the CFFPR are important tools for research, clinical care, and tracking incidence, mortality and population trends.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The US CFFPR is the largest national CF disease registry worldwide, collecting data across > 120 Cystic Fibrosis Foundation-accredited care centers and representing approximately 84% of all people in the United States with CF [14] .”
From Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study (2023) · cites this paper as [14]
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Newborn Screening Showing Decreasing Incidence of Cystic Fibrosis
Hale, J. E., Parad, R. B., & Comeau, A. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0707530 · Cited by 63
Flagged first, then by citations
Research works printed but not linked: 30
- Farrell, 2008, Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report, J Pediatr, 153, S4, 10.1016/j.jpeds.2008.05.005 · DOI
- Doershuk, 2001, Cystic fibrosis in the 20th century: people, events, and progress
- Gliklich, 2014, Registries for evaluating patient outcomes: a user’s guide, 336
- Marshall, 2009, Cystic fibrosis foundation: achieving the mission, Respir Care, 54, 788, 10.4187/002013209790983223 · DOI
- Schechter, 2014, The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement, BMJ Qual Saf, 23, i9, 10.1136/bmjqs-2013-002378 · DOI
- Mall MA, 2014, Cystic fibrosis, 332, 10.1183/1025448x.erm6414 · DOI
- Mogayzel, 2014, Improving chronic care delivery and outcomes: the impact of the cystic fibrosis Care Center Network, BMJ Qual Saf, 23, i3, 10.1136/bmjqs-2013-002363 · DOI
- Knapp, 2015, Estimating the number of individuals with cystic fibrosis in the United States [abstract 502], Pediatr Pulmonol, 50, S381
- Dowd, 2015, The Cystic Fibrosis Foundation Patient Registry (CFFPR) data quality audit program: an analysis of data completeness and data accuracy [abstract 538], Pediatr Pulmonol, 50, S396
- FitzSimmons, 1994, The changing epidemiology of cystic fibrosis, Curr Probl Pediatr, 24, 171, 10.1016/0045-9380(94)90034-5 · DOI
- Martin, 2013, Births: final data for 2012, Natl Vital Stat Rep, 62, 1
- Kaye, 2006, Newborn screening fact sheets, Pediatrics, 118, e934, 10.1542/peds.2006-1783 · DOI
- Comeau, 2004, Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections, Pediatrics, 113, 1573, 10.1542/peds.113.6.1573 · DOI
- Sontag, 2005, Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes, J Pediatr, 147, S83, 10.1016/j.jpeds.2005.08.005 · DOI
- Rock, 2005, Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing, J Pediatr, 147, S73, 10.1016/j.jpeds.2005.08.004 · DOI
- Prach, 2013, Novel CFTR variants identified during the first 3 years of cystic fibrosis newborn screening in California, J Mol Diagn, 15, 710, 10.1016/j.jmoldx.2013.05.006 · DOI
- Feuchtbaum, 2012, Birth prevalence of disorders detectable through newborn screening by race/ethnicity, Genet Med, 14, 937, 10.1038/gim.2012.76 · DOI
- Korzeniewski, 2011, Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening, Pediatr Pulmonol, 46, 125, 10.1002/ppul.21330 · DOI
- Larsson, 2012, Use of 13 disease registries in 5 countries demonstrates the potential to use outcome data to improve health care’s value, Health Aff (Millwood), 31, 220, 10.1377/hlthaff.2011.0762 · DOI
- Sykes, 2016, A standardized approach to estimating survival statistics for population-based cystic fibrosis registry cohorts, J Clin Epidemiol, 70, 206, 10.1016/j.jclinepi.2015.08.026 · DOI
- Mendelsohn, 2015, Characterization of missing data in clinical registry studies, Ther Innov Regul Sci, 49, 146, 10.1177/2168479014532259 · DOI
- Liou, 2007, Lung transplantation and survival in children with cystic fibrosis, N Engl J Med, 357, 2143, 10.1056/NEJMoa066359 · DOI
- Goss, 2004, Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis, Am J Respir Crit Care Med, 169, 816, 10.1164/rccm.200306-779OC · DOI
- Psoter, 2015, Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis, Ann Am Thorac Soc, 12, 385, 10.1513/AnnalsATS.201408-400OC · DOI
- Nick, 2010, Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis, Am J Respir Crit Care Med, 182, 614, 10.1164/rccm.201001-0092OC · DOI
- Ren, 2015, Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening, Pediatrics, 135, e1386, 10.1542/peds.2014-3698 · DOI
- Goss, 2015, Children and young adults with CF in the USA have better lung function compared with the UK, Thorax, 70, 229, 10.1136/thoraxjnl-2014-205718 · DOI
- Motheral, 2003, A checklist for retrospective database studies–report of the ISPOR Task Force on Retrospective Databases, Value Health, 6, 90, 10.1046/j.1524-4733.2003.00242.x · DOI
- Psoter, 2013, Opportunities and pitfalls of registry data for clinical research, Paediatr Respir Rev, 14, 141
- Heltshe, 2016, Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis, Thorax, 71, 223, 10.1136/thoraxjnl-2014-206750 · DOI
Cited by
Sorted by citations
Quittner, A. L., Abbott, J., Georgiopoulos, A. M., Goldbeck, L., Smith, B., Hempstead, S. E., Marshall, B., Sabadosa, K. A., & Elborn, S. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207488 · Cited by 465
Self-citationBower, J. K., Volkova, N., Ahluwalia, N., Sahota, G., Xuan, F., Chin, A., Weinstock, T. G., Ostrenga, J., & Elbert, A. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.03.002 · Cited by 140
Self-citationLechtzin, N., Mayer-Hamblett, N., West, N. E., Allgood, S., Wilhelm, E., Khan, U., Aitken, M. L., Ramsey, B. W., Boyle, M. P., Mogayzel, P. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2172oc · Cited by 127
Self-citationRamos, K. J., Quon, B. S., Heltshe, S. L., Mayer-Hamblett, N., Lease, E. D., Aitken, M. L., Weiss, N. S., & Goss, C. H. (2017) · Chest · doi:10.1016/j.chest.2017.01.019 · Cited by 95
Self-citationDecreased survival in cystic fibrosis patients with a positive screen for depression
Schechter, M. S., Ostrenga, J. S., Fink, A. K., Barker, D. H., Sawicki, G. S., & Quittner, A. L. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.07.020 · Cited by 71
Self-citation
Metadata
- Authors
- Knapp, E. A., Fink, A. K., Goss, C. H., Sewall, A., Ostrenga, J., Dowd, C., Elbert, A., Petren, K. M., & Marshall, B. C.
- Affiliations
- Cystic Fibrosis Foundation, Bethesda, Maryland
- Department of Medicine, University of Washington, Seattle, Washington; and
- Sewall, Inc., Bethesda, Maryland
- ORCID
- Knapp, Emily A.
- Venue
- Annals of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-07-01
- Volume
- 13
- Issue
- 7
- Pages
- 1173-1179
- ISSN
- 2329-6933
- 2325-6621
- Cited by
- 346
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review